Effects of Intermittent Fasting on Brain-Derived Neurotrophic Factor Levels in Adults with Overweight or Obesity: A Scoping Review

Main Article Content

Adetunmise Oluseyi Olajide
Alejandra Gallego Rivas
Amanda Lucia Armendariz Ortiz
Ana Beatriz Sampaio Pinto de Castro
Belkis Gabriela Franco Malaver
Claudia Reyes Aguirre
Cristina Oliveira
Eugenia Rojas
Fatima Ramos
Felipe Marques da Costa
Gabriella Freaza
Hawraa Shwaylia
Iñaki Xavier Bizama Brahm Bizama Brahm
Jarline Esther Cruz Santana
Joao Victor Starling Magalhaes
Jorge Segovia
Jose Valenzuela
Letícia Sanches Kelemen
Lubna Mohammed
Maira Foresti
Maria Luiza Cunha D'avila
Marina Acevedo Zarzar de Melo
Roma Aguiar
Tomislav Rajevic Mosler
Yael Dinur Schejter
Yannick Hurni

Abstract

Background: Overweight and obesity are major public health concerns. Increasing evidence links these conditions to cognitive decline and neurodegenerative disorders, potentially mediated by reduced brain-derived neurotrophic factor (BDNF). Intermittent fasting (IF) has gained attention for its potential metabolic and neuroprotective benefits, possibly increasing BDNF. However, the relationship between IF, BDNF, and cognitive outcomes in overweight and obese individuals remains unclear.


Purpose: This scoping review aimed to systematically map and synthesize the existing evidence on the impact of various IF protocols on BDNF levels in adults with overweight or obesity.


Methods: Following the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews) guidelines, a systematic search was conducted in five databases. Studies including adults with a body mass index ≥25 kg/m² and comparing various IF protocols to continuous caloric restriction or unrestricted diets were considered. The search included studies published up to April 26, 2025. Dual independent screening, data extraction, and risk of bias assessment (RoB 2.0) were performed.


Results: From 22,117 records screened, 6 RCTs (n = 534; 83.5% female; ages 18–70) were identified and mapped. Trials tested alternate-day fasting, time-restricted feeding, and intermittent energy restriction protocols over 8–32 weeks. The evidence mapping revealed that three studies demonstrated significant within-group increases in BDNF, with two also reporting greater increases versus controls; the remaining three trials found no effect. Two studies assessed cognition, but results were inconsistent and showed no clear benefit attributable to IF.


Conclusions: This scoping review mapped heterogeneous evidence suggesting that select IF protocols may elevate BDNF in overweight and obese adults; however, the available evidence exhibits considerable methodological heterogeneity, limiting definitive conclusions. Well-powered, rigorously controlled trials with standardized protocols are warranted to clarify the clinical relevance of BDNF modulation by IF.

Article Details

How to Cite
Effects of Intermittent Fasting on Brain-Derived Neurotrophic Factor Levels in Adults with Overweight or Obesity: A Scoping Review. (2026). Principles and Practice of Clinical Research, 11(3). https://doi.org/10.21801/ppcrj.2025.113.7
Section
View and Review

How to Cite

Effects of Intermittent Fasting on Brain-Derived Neurotrophic Factor Levels in Adults with Overweight or Obesity: A Scoping Review. (2026). Principles and Practice of Clinical Research, 11(3). https://doi.org/10.21801/ppcrj.2025.113.7

Most read articles by the same author(s)

<< < 10 11 12 13 14 15 16 17 18 19 > >>